文献速递银屑病与炎症性皮肤病

免疫调节颗粒抑制单核细胞减轻小鼠银屑病IL-17+γδT细胞反应

Immune Modulation of Monocytes Dampens the IL-17+ γδ T Cell Response and Associated Psoriasis Pathology in Mice.
PubMed 文献 · J Invest Dermatol · 2020-05-07

该研究在小鼠咪喹莫特诱导银屑病模型中,用免疫调节颗粒(IMP)靶向Ly6Chi炎性单核细胞并将其滞留于脾脏,显著减轻银屑病严重程度,减少真皮Ly6Chi单核细胞及早期单核细胞来源真皮巨噬细胞浸润,并降低IL-23、IL-1β及产IL-17的γδT细胞水平。

要点

  • IMP靶向Ly6Chi炎性单核细胞可减轻咪喹莫特诱导的小鼠银屑病严重程度
  • IMP减少真皮Ly6Chi单核细胞和早期单核细胞来源巨噬细胞浸润
  • IMP降低IL-23、IL-1β及产IL-17的γδT细胞水平

核心结论

  • 炎性单核细胞在银屑病发病中起关键作用,IMP对银屑病具有治疗潜力。

研究设计与样本

  • 研究采用咪喹莫特诱导的小鼠银屑病模型,评估IMP对Ly6Chi炎性单核细胞及银屑病发展的影响。

主要发现

  • IMP治疗显著降低咪喹莫特诱导的银屑病严重程度。
  • IMP减少真皮Ly6Chi单核细胞及早期单核细胞来源真皮巨噬细胞浸润。
  • IMP降低IL-23、IL-1β水平及产IL-17的γδT细胞。

临床怎么用

  • 提示靶向炎性单核细胞可能成为银屑病替代治疗策略。

局限性

  • 研究仅基于小鼠咪喹莫特模型,尚未在人类银屑病中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriasis is a chronic inflammatory autoimmune skin condition that affects millions of people worldwide. It is driven by IL-17-producing CD4 and γδ T cells and targeted by current anti-IL-17 or anti-IL-23 mAb therapies. These treatments are expensive, increase the risk of opportunistic infections, and do not specifically target the inflammatory cascade. Other cells, including inflammatory monocytes, have been shown to migrate to psoriatic plaques in both human disease and the imiquimod-induced mouse model and could thus constitute potential alternative therapeutic targets. In the mouse, immune modifying particles (IMPs) specifically target Ly6Chi inflammatory monocytes migrating to the site of inflammation, sequestering them in the spleen. In this project, we determined whether IMPs could mitigate the development of imiquimod -induced psoriasis in mice. IMP treatment significantly reduced imiquimod-induced psoriasis severity, decreasing dermal infiltration of Ly6Chi monocytes as well as early-stage monocyte-derived dermal macrophages. This was associated with reduced levels of hallmark cytokines IL-23 and IL-1β as well as associated IL-17-producing γδ T cells. Our work highlights the crucial importance of inflammatory monocytes in the development of this disease as well as a therapeutic potential for IMP in psoriasis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Pinget GV, Tan J, Niewold P, et al. Immune Modulation of Monocytes Dampens the IL-17+ γδ T Cell Response and Associated Psoriasis Pathology in Mice. J Invest Dermatol. 2020. PMID: 32389535. doi:10.1016/j.jid.2020.03.973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。